0 Ratings
ID

20388

Description

The purpose of the trial is to determine if extended-release dipyridamole + aspirin [Aggrenox, Asasa ntin] is superior to clopidogrel [Plavix], and if telmisartan [Micardis, Gliosartan, Kinzal, Kinzalm ono, Predxal, Pritor, Samertan, Telmisartan] is superior to placebo, in the presence of background antihypertensive therapy, in prevention of a second stroke in patients who have recently suffered a stroke and therefore are at high risk of suffering another one. End of Trial Study Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00153062?term=NCT00153062&rank=1

Link

https://clinicaltrials.gov/ct2/show/NCT00153062?term=NCT00153062&rank=1

Keywords

Versions (1)
  1. 2/21/17 2/21/17 -
Uploaded on

February 21, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

  • Newest
  • Oldest
  • Popular
  • Newest
    • Newest
    • Oldest
    • Popular

    No comments

    In order to download data models you must be logged in. Please log in or register for free.

    End of Trial Concomitant Medication ACE Inhibitors PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

    English

    End of Trial Concomitant Medication ACE Inhibitors PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

    1 forms  
    Concomitant Medication
    Description

    Concomitant Medication

    Alias
    UMLS CUI-1
    C2347852
    1. Since the visit 5, were any of the non-study medications listed below taken?
    Description

    Medication taken

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C1553892
    If yes, please indicate which of the following were being taken:
    Description

    If yes, please indicate which

    Data type

    integer

    Alias
    UMLS CUI [1]
    C1553892
    ACE Inhibitors
    Description

    ACE Inhibitors

    Alias
    UMLS CUI-1
    C0003015
    2. Since the visit 5, were any ACE inhibitors taken?
    Description

    ACE Inhibitors currently taken

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0013227
    If Yes, please indicate which, and total daily dose:
    Description

    Name of ACE Inhibitor and Total Daily Dose

    Data type

    text

    Alias
    UMLS CUI [1,1]
    C0003015
    UMLS CUI [1,2]
    C2360065
    UMLS CUI [2,1]
    C0003015
    UMLS CUI [2,2]
    C2348070
    Restricted Concomitant Medication
    Description

    Restricted Concomitant Medication

    Alias
    UMLS CUI-1
    C2347852
    UMLS CUI-2
    C0233470
    3. Have any restricted medications in the categories defined on the opposite page been taken?
    Description

    Restricted medication taken

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C1518384
    UMLS CUI [1,2]
    C0087111
    If yes, please indicate which category
    Description

    if yes

    Data type

    integer

    Alias
    UMLS CUI [1]
    C0683312
    Back to the top of the page

    Similar models

    End of Trial Concomitant Medication ACE Inhibitors PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

    1 forms
    Name
    Type
    Description | Question | Decode (Coded Value)
    Data type
    Alias
    Item Group
    Concomitant Medication
    C2347852 (UMLS CUI-1)
    Medication taken
    Item
    1. Since the visit 5, were any of the non-study medications listed below taken?
    boolean
    C1553892 (UMLS CUI [1])
    Item
    If yes, please indicate which of the following were being taken:
    integer
    C1553892 (UMLS CUI [1])
    If yes, please indicate which
    Code List
    If yes, please indicate which of the following were being taken:
    CL Item
    Parental anticoagulants (Short term use) (1)
    CL Item
    Oral anticoagulants (Short term use) (2)
    CL Item
    Nitrates (oral or topical) (3)
    CL Item
    Estrogen replacement without progesterone (4)
    CL Item
    Estrogen replacement with progesterone (5)
    CL Item
    Digitalis (6)
    CL Item
    Statins (7)
    CL Item
    Fibrates (8)
    CL Item
    Dilitazem/Verapamil (9)
    CL Item
    Other calcium channel blockers (10)
    CL Item
    Alpha-blocker (11)
    CL Item
    Direct vasodilators (12)
    CL Item
    Peripheral sympatholytic (13)
    CL Item
    Central sympatholytic (14)
    CL Item
    Alpha-beta blocker (15)
    CL Item
    Beta-blocker (16)
    CL Item
    Loop-active diuretics (17)
    CL Item
    Diuretics of thiazide type (18)
    CL Item
    Potassium-sparing diuretics (19)
    CL Item
    Insulin (20)
    CL Item
    Oral hypoglycemic agents (21)
    CL Item
    Specific Cox II inhibitors (22)
    Item Group
    ACE Inhibitors
    C0003015 (UMLS CUI-1)
    ACE Inhibitors currently taken
    Item
    2. Since the visit 5, were any ACE inhibitors taken?
    boolean
    C0013227 (UMLS CUI [1])
    Name of ACE Inhibitor and Total Daily Dose
    Item
    If Yes, please indicate which, and total daily dose:
    text
    C0003015 (UMLS CUI [1,1])
    C2360065 (UMLS CUI [1,2])
    C0003015 (UMLS CUI [2,1])
    C2348070 (UMLS CUI [2,2])
    Item Group
    Restricted Concomitant Medication
    C2347852 (UMLS CUI-1)
    C0233470 (UMLS CUI-2)
    Restricted medication taken
    Item
    3. Have any restricted medications in the categories defined on the opposite page been taken?
    boolean
    C1518384 (UMLS CUI [1,1])
    C0087111 (UMLS CUI [1,2])
    Item
    If yes, please indicate which category
    integer
    C0683312 (UMLS CUI [1])
    if yes
    Code List
    If yes, please indicate which category
    CL Item
    1 (1)
    CL Item
    2 (2)
    CL Item
    3 (3)
    CL Item
    4 (4)
    CL Item
    5 (5)
    CL Item
    6 (6)
    CL Item
    7 (7)
    Back to the top of the page 

    Help

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial